Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Med Case Rep ; 11(1): 133, 2017 May 12.
Artigo em Inglês | MEDLINE | ID: mdl-28494807

RESUMO

BACKGROUND: Clear cell carcinoma of the bladder is a rare variant of urinary bladder adenocarcinoma. We report a case of a patient with clear cell carcinoma of the bladder and a concordant right upper lobe pulmonary adenocarcinoma with clear cell features, and we address the role of immunohistochemistry and cytogenetic analysis in distinguishing the two primary malignancies. CASE PRESENTATION: Our patient was a 59-year-old African American woman who presented with hematuria. Her past medical history included invasive mammary carcinoma and end-stage renal disease treated with hemodialysis. A computed tomographic urogram revealed a 3-cm polypoid bladder mass. A follow-up chest computed tomographic scan revealed a 1-cm right upper lobe nodule. The patient underwent transurethral biopsy and subsequent radical cystectomy, as well as a transthoracic core needle biopsy of the lung nodule. Histologically, the bladder tumor consisted of flat, cuboidal to columnar cells with clear or eosinophilic cytoplasm and a hobnail appearance, organized in tubulocystic and papillary patterns. The neoplastic cells were diffusely positive for α-methylacyl-coenzyme A racemase, cancer antigen 125, and cytokeratin 7; focally positive for cytokeratin 20, P53, and carcinoembryonic antigen; and negative for thyroid transcription factor 1. The lung tumor demonstrated a glandular architecture with mucin production (positive for mucin with mucicarmine and periodic acid-Schiff with diastase stain). The neoplastic cells were diffusely positive for cytokeratin 7, napsin A, and thyroid transcription factor 1, and they were negative for cytokeratin 20 and cancer antigen 125. Genetic testing of the pulmonary neoplasm demonstrated ARID2 genomic alterations. CONCLUSIONS: The presence of clear cell features in both neoplasms raised the possibility of lung metastasis from the primary bladder tumor. However, the glandular architecture of the lung neoplasm along with its distinctive immunohistochemical and genetic profiles confirmed the presence of two separate primaries.


Assuntos
Adenocarcinoma de Células Claras/diagnóstico , Adenocarcinoma/diagnóstico , Neoplasias Pulmonares/diagnóstico , Neoplasias Primárias Múltiplas/diagnóstico , Neoplasias da Bexiga Urinária/diagnóstico , Adenocarcinoma/terapia , Adenocarcinoma de Pulmão , Adenocarcinoma de Células Claras/terapia , Biomarcadores Tumorais/genética , Cistectomia , Feminino , Testes Genéticos , Hematúria , Humanos , Histerectomia , Imuno-Histoquímica , Neoplasias Pulmonares/terapia , Pessoa de Meia-Idade , Neoplasias Primárias Múltiplas/terapia , Radioterapia Adjuvante , Salpingo-Ooforectomia , Tomografia Computadorizada por Raios X , Fatores de Transcrição/genética , Resultado do Tratamento , Neoplasias da Bexiga Urinária/terapia
2.
Diagn Cytopathol ; 41(5): 408-12, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-22351503

RESUMO

Case-control studies have demonstrated that the ThinPrep Pap test may provide improved detection of endometrial carcinoma. The purpose of this study is to prospectively examine the diagnostic potential of the ThinPrep Pap test in the detection of endometrial carcinoma. ThinPrep Pap test slides were collected from high-risk patient groups. Pap-stained slides were reviewed and the cytological diagnosis was rendered independently by investigators. Each case was assigned to one of the four diagnostic categories: within normal limit (WNL); atypical glandular cells (AGC); atypical endometrial cells (AEC); or adenocarcinoma, probably endometrial origin. After cytological diagnosis was made, the histological follow-up diagnosis was obtained through the laboratory information system and the cyto-histological correlation was analyzed. Of 106 patients identified, 60 had histological follow-up. For all eight cases interpreted by cytology as positive, endometrial carcinoma was confirmed histologically. Among 25 patients with normal endometrial cells present, histological follow-up showed benign endometrium. Among 17 cases interpreted cytologically as AEC, 14 cases (82.4%) had benign histological follow-up and 3 cases (17.6%) had endometrial carcinoma. All 11 cases (100%) classified as AGC had benign histological follow-up. The sensitivity and specificity of detecting endometrial malignancy were 72.7% and 100%, respectively. The positive predictive value was 100%. In this prospective study, we demonstrated that the Thin Prep Pap test had a reasonably high sensitivity and/or specificity in detecting endometrial carcinoma.


Assuntos
Adenocarcinoma/patologia , Neoplasias do Endométrio/patologia , Adenocarcinoma/diagnóstico , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias do Endométrio/diagnóstico , Endométrio/patologia , Feminino , Seguimentos , Humanos , Pessoa de Meia-Idade , Estudos Prospectivos , Sensibilidade e Especificidade , Esfregaço Vaginal
3.
J Oral Maxillofac Surg ; 67(7): 1495-8, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19531423

RESUMO

PURPOSE: To report an unusual case of severe maxillary sinusitis resulting from ostial plugging by dislodged bone graft material used for sinus elevation procedure. PATIENTS AND METHODS: A 49-year-old female presented to the oral surgery clinic with severe right maxillary sinusitis after a sinus elevation procedure and placement of a dental implant. She had completed an extended course of multiple antibiotics without culture and sensitivity studies or resolution of sinusitis. RESULTS: A CT scan was obtained which showed a dental implant protruding into the right maxillary sinus, sinusitis of the right ethmoid and maxillary sinuses, and dislodged bone graft material obstructing the ostium into the middle nasal meatus. The dental implant was removed, the patient was referred for functional endoscopic sinus surgery, and her sinusitis subsequently rapidly resolved. CONCLUSIONS: Surgeons performing this or similar procedures should be aware of the possible complications that can arise from foreign debris introduced into the maxillary sinuses. Also, the avoidance of empirically changing antibiotic regimens and the early use of CT scans should be considered.


Assuntos
Transplante Ósseo/efeitos adversos , Implantes Dentários para Um Único Dente/efeitos adversos , Corpos Estranhos/complicações , Seio Maxilar/lesões , Sinusite Maxilar/etiologia , Transplante Ósseo/diagnóstico por imagem , Implantação Dentária Endóssea/efeitos adversos , Seio Etmoidal/lesões , Feminino , Humanos , Seio Maxilar/diagnóstico por imagem , Seio Maxilar/cirurgia , Sinusite Maxilar/cirurgia , Pessoa de Meia-Idade , Pólipos Nasais/etiologia , Tomografia Computadorizada por Raios X
4.
Am J Obstet Gynecol ; 197(3): 281.e1-8, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17826421

RESUMO

OBJECTIVE: In utero exposure to repeated doses of antenatal corticosteroids (ACSs) has been shown to reduce fetal growth. Our goal was to evaluate whether weekly betamethasone (R-ACS) alters placental growth and histologic findings. STUDY DESIGN: In a multicenter randomized controlled trial of R-ACS vs a single course of ACS followed by weekly placebo (S-ACS), placentas were weighed after removal of the membranes and umbilical cord. A single pathologist who was masked to study group and pregnancy outcomes performed histologic evaluation for placental calcifications, infarction, fibrin deposition, and hemorrhage or thrombus formation, acute and chronic chorioamnionitis, fibromuscular vascular hyperplasia, nucleated red blood cells, and villous crowding, edema, fibrosis, or fibrinoid necrosis. Findings were compared between study groups and according to the number of courses of ACS. RESULTS: One hundred ninety-four placentas were available for evaluation. Univariable analyses revealed no differences between study groups in any of the 19 evaluated histologic parameters between R-ACS and S-ACS groups overall or in analyses that were restricted to deliveries at < 32 or > or = 32 weeks of gestation. Calcifications were more common (P = .045) in the R-ACS group after controlling for other factors. Multivariable analysis revealed increasing gestational age at delivery, but not increasing ACS courses, to be associated with decreasing chorionic inflammation, villous edema, and fibrosis and with increasing villus crowding, fibrin deposition, and calcifications. Ninety-three placentas were weighed before formalin fixation. After controlling for delivery gestation and infant gender, placental weight was significantly lower in the R-ACS group (P = .017) and was related inversely to the number of ACS courses (P = .037). This finding was confirmed only for deliveries at > or = 32 weeks of gestation (525 vs 441 g for R-ACS and S-ACS group, respectively; P = .036). CONCLUSION: Repeated antenatal corticosteroid treatments in pregnancy are associated with decreased placental growth in a dose-dependent fashion, but not with evident differences in histologic markers of placental inflammation, ischemia, or infarction. Histologic placental abnormalities should not be attributed to repeated courses of corticosteroids.


Assuntos
Betametasona/farmacologia , Glucocorticoides/farmacologia , Placenta/patologia , Placentação , Lesões Pré-Natais/induzido quimicamente , Adulto , Relação Dose-Resposta a Droga , Método Duplo-Cego , Feminino , Idade Gestacional , Humanos , Placenta/anormalidades , Placenta/efeitos dos fármacos , Gravidez
5.
Gynecol Oncol ; 105(1): 244-7, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17316775

RESUMO

BACKGROUND: Mixed yolk sac tumors of the ovary are biologically aggressive even in early stage disease. CASE: A 41-year-old woman presented with a large pelvic mass and anterior vaginal wall tumor. At surgery vaginal biopsies were performed followed by an exploratory laparotomy with resection of the mass. Pathology of the ovary revealed a primary yolk sac tumor associated with poorly differentiated endometrioid and undifferentiated carcinoma with vaginal metastasis only. She was initiated on bleomycin, etoposide, and cisplatin, with three additional cycles of etoposide and cisplatin. Initially the patient experienced a complete response, however her disease recurred and she currently is dead of her disease. CONCLUSION: To our knowledge this is the first case of a mixed ovarian germ cell tumor with vaginal metastasis.


Assuntos
Carcinoma Endometrioide/secundário , Tumor do Seio Endodérmico/secundário , Neoplasias Ovarianas/patologia , Neoplasias Vaginais/secundário , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Bleomicina/administração & dosagem , Carcinoma Endometrioide/tratamento farmacológico , Carcinoma Endometrioide/patologia , Cisplatino/administração & dosagem , Tumor do Seio Endodérmico/tratamento farmacológico , Tumor do Seio Endodérmico/patologia , Etoposídeo/administração & dosagem , Feminino , Humanos , Neoplasias Ovarianas/tratamento farmacológico , Neoplasias Vaginais/tratamento farmacológico
6.
Ann Neurol ; 52(6): 836-42, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12447940

RESUMO

A unique phenotype of Waardenburg-Hirschsprung disease (WS4) accompanied by peripheral neuropathy and central dysmyelination has been recognized recently in association with SOX10 mutations. We report an infant boy with lethal congenital hypomyelinating neuropathy and WS4 who had a heterozygous SOX10 mutation (Q250X). Histopathological studies showed an absence of peripheral nerve myelin despite normal numbers of Schwann cells and profound dysmyelination in the central nervous system. These observations suggest that some SOX10 mutations such as Q250X may allow Schwann cells and oligodendrocytes to proliferate but interfere with further differentiation to form myelin. In contrast with the SOX10 loss-of-function mutations causing only WS4, mutations associated with both peripheral and central dysmyelination may affect pathology through a dominant-negative mechanism.


Assuntos
Proteínas de Ligação a DNA/genética , Proteínas de Grupo de Alta Mobilidade/genética , Doença de Hirschsprung/genética , Mutação/genética , Doenças do Sistema Nervoso Periférico/genética , Síndrome de Waardenburg/genética , Doenças Desmielinizantes/congênito , Doenças Desmielinizantes/genética , Doenças Desmielinizantes/patologia , Feminino , Doença de Hirschsprung/patologia , Humanos , Recém-Nascido , Masculino , Linhagem , Doenças do Sistema Nervoso Periférico/congênito , Doenças do Sistema Nervoso Periférico/patologia , Fenótipo , Fatores de Transcrição SOXE , Fatores de Transcrição , Síndrome de Waardenburg/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...